Consultez les derniers articles autour de la maladie de Willebrand
Dernière mise à jour : Vendredi 04 juillet 2025Neuraxial anesthesia is used for pain management in surgical and nonsurgical settings. Spinal/epidural hematomas likely occur in between 1:10 000 and 1:200 000 procedures. Risk is believed to be greater...
Lire la suite
Von Willebrand disease (VWD) reflects the most common inherited bleeding disorder, arising from defects or deficiencies in the von Willebrand factor (VWF). VWD treatment mostly relies on the replacement...
Lire la suite
Acquired von Willebrand syndrome (AVWS) is a well-known complication of a monoclonal gammopathy with a potentially severe bleeding tendency. Treatment with von Willebrand factor (VWF)/factor VIII (FVIII)...
Lire la suite
Von Willebrand disease (VWD) type 2 arises from variants in von Willebrand factor (VWF) that disrupt its essential hemostatic functions. Per ISTH guidelines, it is classified as type 2A, 2B, 2M, and 2N based on the affected VWF roles.Objectives: This population-based study aims to uncover the genotype and laboratory phenotypes in type 2 VWD, providing insights into underlying genetics and genotype-phenotype associations....
Lire la suite
2 Current and emerging therapies as potential treatment for people with von Willebrand disease
Expert Review of Hematology 2024; 17(12): 917-333 Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case series.
Therapeutic advances in hematology 2025 ; 16: 20406207251347235